about
Assessing the performance of the Birmingham Vasculitis Activity Score at diagnosis for children with antineutrophil cytoplasmic antibody-associated vasculitis in A Registry for Childhood Vasculitis (ARChiVe).Do adult disease severity subclassifications predict use of cyclophosphamide in children with ANCA-associated vasculitis? An analysis of ARChiVe study treatment decisions.Familial Takayasu arteritis - a pediatric case and a review of the literature.Comparing Presenting Clinical Features in 48 Children With Microscopic Polyangiitis to 183 Children Who Have Granulomatosis With Polyangiitis (Wegener's): An ARChiVe Cohort Study.Early Outcomes in Children With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.Musculoskeletal manifestations of mucopolysaccharidoses.Clinical practice variation and need for pediatric-specific treatment guidelines among rheumatologists caring for children with ANCA-associated vasculitis: an international clinician survey.Pediatric vasculitis: advances in treatment.Health-related quality of life in an inception cohort of children with Juvenile Idiopathic Arthritis: A longitudinal analysis.The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort.Mortality in Wegener's granulomatosis: a bimodal pattern.Guidelines for blood test monitoring of methotrexate toxicity in juvenile idiopathic arthritis.The risk and nature of flares in juvenile idiopathic arthritis: results from the reACCh-Out cohort.The importance of considering monogenic causes of autoimmunity: A somatic mutation in KRAS causing pediatric Rosai-Dorfman syndrome and systemic lupus erythematosus.Prospective Determination of the Incidence and Risk Factors of New-Onset Uveitis in Juvenile Idiopathic Arthritis: The Research in Arthritis in Canadian Children Emphasizing Outcomes CohortEarly Atlantoaxial Subluxation in Enthesitis-related ArthritisChylous Pericardial Effusion in Granulomatosis with PolyangiitisSerious musculoskeletal infections in children receiving anti-tumor necrosis factor-α therapy: a case seriesInnate Control of Tissue-Reparative Human Regulatory T CellsIdentification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric VasculitisPredicting Which Children with Juvenile Idiopathic Arthritis Will Not Attain Early Remission with Conventional Treatment: Results from the ReACCh-Out CohortNatural history and extracutaneous involvement of congenital morphea: Multicenter retrospective cohort study and literature review
P50
Q34159902-AE1A0CA7-87FC-4093-A3AB-724A86AD1B79Q34363915-FB5E62F0-A42B-4BA6-8907-ED83CCE0413EQ34593118-EE8CB1C7-8655-4028-8911-698EF6B8E85BQ35998297-9EDC4AF8-B7F2-44A0-AA33-996C83CA61A4Q36332824-ACF051BF-2C93-4BF1-BA83-23E20224E19CQ36618597-1537127F-A838-43E8-8A29-1D1DE9342F8EQ37972586-B1511CA2-1373-4C8F-9DE9-AE68F97DACB4Q38372499-C9C4E9E8-D0DE-48AF-B37C-2A6112FDC41AQ38543140-0ED11273-BF95-4336-BCFE-112065B4EB8CQ40284612-C063B665-300D-4823-B11B-2E4489965D49Q44646094-5A3274E9-829B-4D84-B4D0-C51F24B83254Q44964147-F307DC7E-8A9E-4306-B0DE-159B09A17EB8Q45167254-FD2E60CA-82F2-4F22-AF08-BC8A2C5EB4E8Q46861333-92C0C739-C11D-4BE9-A256-242E1537645DQ51222177-96D316C3-00FA-4BA6-B1CB-60D85A43A2DDQ57461369-E33AE357-3B6D-4945-9AFB-34E3C8A038D1Q57910590-1804B833-54C2-4012-8E19-8DC617E884F3Q59160676-A2E5D99D-B416-4163-B1FA-DF0BCBF0E260Q59160690-3381295F-C589-4A02-9C9E-00ED62A14E0EQ62682510-BFABDA37-37FC-4711-B64E-7FDAB7474E12Q90125189-6478562E-883E-478D-A46C-6961B3EF89B9Q91062269-A847300D-6A8E-406B-A5CE-389BF4DFC44EQ91312921-B02624D3-DDB0-45F8-8DFE-5673C0C6EE87
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-1389-4002
@en
name
Kimberly A. Morishita
@ast
Kimberly A. Morishita
@en
Kimberly A. Morishita
@es
Kimberly A. Morishita
@nl
type
label
Kimberly A. Morishita
@ast
Kimberly A. Morishita
@en
Kimberly A. Morishita
@es
Kimberly A. Morishita
@nl
prefLabel
Kimberly A. Morishita
@ast
Kimberly A. Morishita
@en
Kimberly A. Morishita
@es
Kimberly A. Morishita
@nl
P106
P21
P31
P496
0000-0002-1389-4002